Skip to main content
. 2019 Dec 23;3(24):4228–4237. doi: 10.1182/bloodadvances.2019000925

Table 5.

Multivariable analysis of factors predicting OS in t-ALL

HR (95% CI) P
Sex (male vs female) 1.72 (0.95-3.12) .07
Topoisomerase II inhibitors (yes vs no) 2 (0.97-4) .06
Radiotherapy (yes vs no) 1.03 (0.55-2) .92
Response to first induction (CR/CRi vs refractory) 1.72 (0.74-4.01) .20
Performance of HCT (yes vs no) 0.41 (0.20-0.82) .01